Listed

CONMED Corp

CNMDNYSECIK 816956HealthcareFiscal year ends Dec 31

Latest reported revenue, Q2 FY2026$343.5mRevenue, Q2 FY2026, three months to 2026-06-30$343.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-07-29, accession 0000816956-26-000102.Report this figureThree months to Jun 30, 2026, from the 10-Q filed Jul 29, 2026.

Latest quarter: Q2 FY2026

Three months to Jun 30, 2026, against the same quarter a year earlier.

  • Revenue$343.5mRevenue, Q2 FY2026, three months to 2026-06-30$343.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-07-29, accession 0000816956-26-000102.Report this figure+0.3% on a year earlier
  • Gross margin57.5%Gross margin, Q2 FY2026, three months to 2026-06-30. gross profit / revenueGross profit: $197.5m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-07-29, accession 0000816956-26-000102.Revenue: $343.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-07-29, accession 0000816956-26-000102.Report this figure+2.5 pts on a year earlier
  • Operating margin10.6%Operating margin, Q2 FY2026, three months to 2026-06-30. operating income / revenueOperating income: $36.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-07-29, accession 0000816956-26-000102.Revenue: $343.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-07-29, accession 0000816956-26-000102.Report this figure−0.5 pts on a year earlier
  • Net margin6.7%Net margin, Q2 FY2026, three months to 2026-06-30. net income / revenueNet income: $23.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-07-29, accession 0000816956-26-000102.Revenue: $343.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-07-29, accession 0000816956-26-000102.Report this figure+0.5 pts on a year earlier
  • Diluted EPS$0.77Diluted EPS, Q2 FY2026, three months to 2026-06-30$0.77 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-07-29, accession 0000816956-26-000102.Report this figure+11.6% on a year earlier
  • Free cash flownot reported (Operating cash flow and Capital expenditure not reported)No year-earlier figure to compare

Last eight quarters

Full statements
Revenue$343.5mGross margin 57.5%
Diluted EPS$0.77, Q2 FY2026
Free cash flow$41.2m, Q4 FY2025
CONMED Corp, key figures for the last eight quarters
Line itemUnitQ2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q2 FY20262026-06-30Shape over the periods
Revenue$m332Revenue, Q2 FY2024, three months to 2024-06-30$332.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-07-31, accession 0000816956-25-000028.Report this figure317Revenue, Q3 FY2024, three months to 2024-09-30$316.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-06, accession 0000816956-25-000056.Report this figure346Revenue, Q4 FY2024, three months to 2024-12-31$345.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-17, accession 0000816956-26-000009. Derived: 12-month figure less the 9-month figure.Report this figure321Revenue, Q1 FY2025, three months to 2025-03-31$321.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-05-01, accession 0000816956-25-000011.Report this figure342Revenue, Q2 FY2025, three months to 2025-06-30$342.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-07-29, accession 0000816956-26-000102.Report this figure338Revenue, Q3 FY2025, three months to 2025-09-30$337.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-06, accession 0000816956-25-000056.Report this figure373Revenue, Q4 FY2025, three months to 2025-12-31$373.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-17, accession 0000816956-26-000009. Derived: 12-month figure less the 9-month figure.Report this figure343Revenue, Q2 FY2026, three months to 2026-06-30$343.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-07-29, accession 0000816956-26-000102.Report this figure
Gross margin%55.3%Gross margin, Q2 FY2024, three months to 2024-06-30. gross profit / revenueGross profit: $183.7m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-07-31, accession 0000816956-25-000028.Revenue: $332.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-07-31, accession 0000816956-25-000028.Report this figure56.5%Gross margin, Q3 FY2024, three months to 2024-09-30. gross profit / revenueGross profit: $179.0m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-06, accession 0000816956-25-000056.Revenue: $316.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-06, accession 0000816956-25-000056.Report this figure57.3%Gross margin, Q4 FY2024, three months to 2024-12-31. gross profit / revenueGross profit: $198.3m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-02-17, accession 0000816956-26-000009. Derived: 12-month figure less the 9-month figure.Revenue: $345.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-17, accession 0000816956-26-000009. Derived: 12-month figure less the 9-month figure.Report this figure55.3%Gross margin, Q1 FY2025, three months to 2025-03-31. gross profit / revenueGross profit: $177.8m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-05-01, accession 0000816956-25-000011.Revenue: $321.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-05-01, accession 0000816956-25-000011.Report this figure55.0%Gross margin, Q2 FY2025, three months to 2025-06-30. gross profit / revenueGross profit: $188.3m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-07-29, accession 0000816956-26-000102.Revenue: $342.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-07-29, accession 0000816956-26-000102.Report this figure49.2%Gross margin, Q3 FY2025, three months to 2025-09-30. gross profit / revenueGross profit: $166.1m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-06, accession 0000816956-25-000056.Revenue: $337.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-06, accession 0000816956-25-000056.Report this figure58.5%Gross margin, Q4 FY2025, three months to 2025-12-31. gross profit / revenueGross profit: $218.3m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-02-17, accession 0000816956-26-000009. Derived: 12-month figure less the 9-month figure.Revenue: $373.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-17, accession 0000816956-26-000009. Derived: 12-month figure less the 9-month figure.Report this figure57.5%Gross margin, Q2 FY2026, three months to 2026-06-30. gross profit / revenueGross profit: $197.5m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-07-29, accession 0000816956-26-000102.Revenue: $343.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-07-29, accession 0000816956-26-000102.Report this figure
Operating margin%14.2%Operating margin, Q2 FY2024, three months to 2024-06-30. operating income / revenueOperating income: $47.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-07-31, accession 0000816956-25-000028.Revenue: $332.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-07-31, accession 0000816956-25-000028.Report this figure20.7%Operating margin, Q3 FY2024, three months to 2024-09-30. operating income / revenueOperating income: $65.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-06, accession 0000816956-25-000056.Revenue: $316.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-06, accession 0000816956-25-000056.Report this figure15.2%Operating margin, Q4 FY2024, three months to 2024-12-31. operating income / revenueOperating income: $52.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-17, accession 0000816956-26-000009. Derived: 12-month figure less the 9-month figure.Revenue: $345.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-17, accession 0000816956-26-000009. Derived: 12-month figure less the 9-month figure.Report this figure5.0%Operating margin, Q1 FY2025, three months to 2025-03-31. operating income / revenueOperating income: $16.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-01, accession 0000816956-25-000011.Revenue: $321.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-05-01, accession 0000816956-25-000011.Report this figure11.1%Operating margin, Q2 FY2025, three months to 2025-06-30. operating income / revenueOperating income: $38.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-07-29, accession 0000816956-26-000102.Revenue: $342.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-07-29, accession 0000816956-26-000102.Report this figure3.5%Operating margin, Q3 FY2025, three months to 2025-09-30. operating income / revenueOperating income: $11.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-06, accession 0000816956-25-000056.Revenue: $337.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-06, accession 0000816956-25-000056.Report this figure9.8%Operating margin, Q4 FY2025, three months to 2025-12-31. operating income / revenueOperating income: $36.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-17, accession 0000816956-26-000009. Derived: 12-month figure less the 9-month figure.Revenue: $373.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-17, accession 0000816956-26-000009. Derived: 12-month figure less the 9-month figure.Report this figure10.6%Operating margin, Q2 FY2026, three months to 2026-06-30. operating income / revenueOperating income: $36.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-07-29, accession 0000816956-26-000102.Revenue: $343.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-07-29, accession 0000816956-26-000102.Report this figure
Net margin%9.0%Net margin, Q2 FY2024, three months to 2024-06-30. net income / revenueNet income: $30.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-07-31, accession 0000816956-25-000028.Revenue: $332.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-07-31, accession 0000816956-25-000028.Report this figure15.5%Net margin, Q3 FY2024, three months to 2024-09-30. net income / revenueNet income: $49.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-06, accession 0000816956-25-000056.Revenue: $316.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-06, accession 0000816956-25-000056.Report this figure9.8%Net margin, Q4 FY2024, three months to 2024-12-31. net income / revenueNet income: $33.8m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-17, accession 0000816956-26-000009. Derived: 12-month figure less the 9-month figure.Revenue: $345.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-17, accession 0000816956-26-000009. Derived: 12-month figure less the 9-month figure.Report this figure1.9%Net margin, Q1 FY2025, three months to 2025-03-31. net income / revenueNet income: $6.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-05-01, accession 0000816956-25-000011.Revenue: $321.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-05-01, accession 0000816956-25-000011.Report this figure6.3%Net margin, Q2 FY2025, three months to 2025-06-30. net income / revenueNet income: $21.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-07-29, accession 0000816956-26-000102.Revenue: $342.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-07-29, accession 0000816956-26-000102.Report this figure0.8%Net margin, Q3 FY2025, three months to 2025-09-30. net income / revenueNet income: $2.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-06, accession 0000816956-25-000056.Revenue: $337.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-06, accession 0000816956-25-000056.Report this figure4.5%Net margin, Q4 FY2025, three months to 2025-12-31. net income / revenueNet income: $16.7m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-17, accession 0000816956-26-000009. Derived: 12-month figure less the 9-month figure.Revenue: $373.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-17, accession 0000816956-26-000009. Derived: 12-month figure less the 9-month figure.Report this figure6.7%Net margin, Q2 FY2026, three months to 2026-06-30. net income / revenueNet income: $23.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-07-29, accession 0000816956-26-000102.Revenue: $343.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-07-29, accession 0000816956-26-000102.Report this figure
Diluted EPS$ per share0.96Diluted EPS, Q2 FY2024, three months to 2024-06-30$0.96 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-07-31, accession 0000816956-25-000028.Report this figure1.57Diluted EPS, Q3 FY2024, three months to 2024-09-30$1.57 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-06, accession 0000816956-25-000056.Report this figurenot reported (Diluted EPS not reported)0.19Diluted EPS, Q1 FY2025, three months to 2025-03-31$0.19 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-01, accession 0000816956-25-000011.Report this figure0.69Diluted EPS, Q2 FY2025, three months to 2025-06-30$0.69 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-07-29, accession 0000816956-26-000102.Report this figure0.09Diluted EPS, Q3 FY2025, three months to 2025-09-30$0.09 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-06, accession 0000816956-25-000056.Report this figurenot reported (Diluted EPS not reported)0.77Diluted EPS, Q2 FY2026, three months to 2026-06-30$0.77 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-07-29, accession 0000816956-26-000102.Report this figure
Free cash flow$m39.7Free cash flow, Q2 FY2024, three months to 2024-06-30. operating cash flow − capital expenditureOperating cash flow: $43.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-07-31, accession 0000816956-25-000028. Derived: 6-month figure less the 3-month figure.Capital expenditure: $3.6m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-07-31, accession 0000816956-25-000028. Derived: 6-month figure less the 3-month figure.Report this figure47.8Free cash flow, Q3 FY2024, three months to 2024-09-30. operating cash flow − capital expenditureOperating cash flow: $51.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-06, accession 0000816956-25-000056. Derived: 9-month figure less the 6-month figure.Capital expenditure: $3.4m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-06, accession 0000816956-25-000056. Derived: 9-month figure less the 6-month figure.Report this figure39.3Free cash flow, Q4 FY2024, three months to 2024-12-31. operating cash flow − capital expenditureOperating cash flow: $43.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-17, accession 0000816956-26-000009. Derived: 12-month figure less the 9-month figure.Capital expenditure: $4.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-17, accession 0000816956-26-000009. Derived: 12-month figure less the 9-month figure.Report this figure37.8Free cash flow, Q1 FY2025, three months to 2025-03-31. operating cash flow − capital expenditureOperating cash flow: $41.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-01, accession 0000816956-25-000011.Capital expenditure: $3.8m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-01, accession 0000816956-25-000011.Report this figure23.4Free cash flow, Q2 FY2025, three months to 2025-06-30. operating cash flow − capital expenditureOperating cash flow: $29.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-07-29, accession 0000816956-26-000102. Derived: 6-month figure less the 3-month figure.Capital expenditure: $5.7m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-07-29, accession 0000816956-26-000102. Derived: 6-month figure less the 3-month figure.Report this figure48.5Free cash flow, Q3 FY2025, three months to 2025-09-30. operating cash flow − capital expenditureOperating cash flow: $53.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-06, accession 0000816956-25-000056. Derived: 9-month figure less the 6-month figure.Capital expenditure: $5.2m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-06, accession 0000816956-25-000056. Derived: 9-month figure less the 6-month figure.Report this figure41.2Free cash flow, Q4 FY2025, three months to 2025-12-31. operating cash flow − capital expenditureOperating cash flow: $46.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-17, accession 0000816956-26-000009. Derived: 12-month figure less the 9-month figure.Capital expenditure: $5.1m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-17, accession 0000816956-26-000009. Derived: 12-month figure less the 9-month figure.Report this figurenot reported (Operating cash flow and Capital expenditure not reported)

Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.

Last five fiscal years

Revenue$1.37bnGross margin 54.6%
Diluted EPS$1.51, FY2025
Free cash flow$150.9m, FY2025
CONMED Corp, key figures for the last five fiscal years
Line itemUnitFY20212021-12-31FY20222022-12-31FY20232023-12-31FY20242024-12-31FY20252025-12-31Shape over the periods
Revenue$m1,011Revenue, FY2021, twelve months to 2021-12-31$1.01bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-02-28, accession 0000816956-24-000003.Report this figure1,045Revenue, FY2022, twelve months to 2022-12-31$1.05bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-02-18, accession 0000816956-25-000004.Report this figure1,245Revenue, FY2023, twelve months to 2023-12-31$1.24bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-17, accession 0000816956-26-000009.Report this figure1,307Revenue, FY2024, twelve months to 2024-12-31$1.31bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-17, accession 0000816956-26-000009.Report this figure1,375Revenue, FY2025, twelve months to 2025-12-31$1.37bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-17, accession 0000816956-26-000009.Report this figure
Gross margin%56.2%Gross margin, FY2021, twelve months to 2021-12-31. gross profit / revenueGross profit: $568.0m. XBRL concept us-gaap:GrossProfit. 10-K filed 2024-02-28, accession 0000816956-24-000003.Revenue: $1.01bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-02-28, accession 0000816956-24-000003.Report this figure54.6%Gross margin, FY2022, twelve months to 2022-12-31. gross profit / revenueGross profit: $571.2m. XBRL concept us-gaap:GrossProfit. 10-K filed 2025-02-18, accession 0000816956-25-000004.Revenue: $1.05bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-02-18, accession 0000816956-25-000004.Report this figure54.3%Gross margin, FY2023, twelve months to 2023-12-31. gross profit / revenueGross profit: $676.2m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-02-17, accession 0000816956-26-000009.Revenue: $1.24bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-17, accession 0000816956-26-000009.Report this figure56.1%Gross margin, FY2024, twelve months to 2024-12-31. gross profit / revenueGross profit: $733.0m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-02-17, accession 0000816956-26-000009.Revenue: $1.31bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-17, accession 0000816956-26-000009.Report this figure54.6%Gross margin, FY2025, twelve months to 2025-12-31. gross profit / revenueGross profit: $750.5m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-02-17, accession 0000816956-26-000009.Revenue: $1.37bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-17, accession 0000816956-26-000009.Report this figure
Operating margin%10.9%Operating margin, FY2021, twelve months to 2021-12-31. operating income / revenueOperating income: $109.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2024-02-28, accession 0000816956-24-000003.Revenue: $1.01bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-02-28, accession 0000816956-24-000003.Report this figure6.7%Operating margin, FY2022, twelve months to 2022-12-31. operating income / revenueOperating income: $70.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-02-18, accession 0000816956-25-000004.Revenue: $1.05bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-02-18, accession 0000816956-25-000004.Report this figure9.7%Operating margin, FY2023, twelve months to 2023-12-31. operating income / revenueOperating income: $120.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-17, accession 0000816956-26-000009.Revenue: $1.24bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-17, accession 0000816956-26-000009.Report this figure15.3%Operating margin, FY2024, twelve months to 2024-12-31. operating income / revenueOperating income: $200.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-17, accession 0000816956-26-000009.Revenue: $1.31bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-17, accession 0000816956-26-000009.Report this figure7.5%Operating margin, FY2025, twelve months to 2025-12-31. operating income / revenueOperating income: $102.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-17, accession 0000816956-26-000009.Revenue: $1.37bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-17, accession 0000816956-26-000009.Report this figure
Net margin%6.2%Net margin, FY2021, twelve months to 2021-12-31. net income / revenueNet income: $62.5m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2024-02-28, accession 0000816956-24-000003.Revenue: $1.01bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-02-28, accession 0000816956-24-000003.Report this figure(7.7%)Net margin, FY2022, twelve months to 2022-12-31. net income / revenueNet income: −$80.6m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-02-18, accession 0000816956-25-000004.Revenue: $1.05bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-02-18, accession 0000816956-25-000004.Report this figure5.2%Net margin, FY2023, twelve months to 2023-12-31. net income / revenueNet income: $64.5m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-17, accession 0000816956-26-000009.Revenue: $1.24bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-17, accession 0000816956-26-000009.Report this figure10.1%Net margin, FY2024, twelve months to 2024-12-31. net income / revenueNet income: $132.4m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-17, accession 0000816956-26-000009.Revenue: $1.31bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-17, accession 0000816956-26-000009.Report this figure3.4%Net margin, FY2025, twelve months to 2025-12-31. net income / revenueNet income: $47.1m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-17, accession 0000816956-26-000009.Revenue: $1.37bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-17, accession 0000816956-26-000009.Report this figure
Diluted EPS$ per share1.94Diluted EPS, FY2021, twelve months to 2021-12-31$1.94 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2024-02-28, accession 0000816956-24-000003.Report this figure(2.68)Diluted EPS, FY2022, twelve months to 2022-12-31−$2.68 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2025-02-18, accession 0000816956-25-000004.Report this figure2.04Diluted EPS, FY2023, twelve months to 2023-12-31$2.04 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-02-17, accession 0000816956-26-000009.Report this figure4.25Diluted EPS, FY2024, twelve months to 2024-12-31$4.25 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-02-17, accession 0000816956-26-000009.Report this figure1.51Diluted EPS, FY2025, twelve months to 2025-12-31$1.51 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-02-17, accession 0000816956-26-000009.Report this figure
Free cash flow$m96.9Free cash flow, FY2021, twelve months to 2021-12-31. operating cash flow − capital expenditureOperating cash flow: $111.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2024-02-28, accession 0000816956-24-000003.Capital expenditure: $14.9m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2024-02-28, accession 0000816956-24-000003.Report this figure11.6Free cash flow, FY2022, twelve months to 2022-12-31. operating cash flow − capital expenditureOperating cash flow: $33.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-02-18, accession 0000816956-25-000004.Capital expenditure: $21.8m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-02-18, accession 0000816956-25-000004.Report this figure106Free cash flow, FY2023, twelve months to 2023-12-31. operating cash flow − capital expenditureOperating cash flow: $125.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-17, accession 0000816956-26-000009.Capital expenditure: $19.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-17, accession 0000816956-26-000009.Report this figure154Free cash flow, FY2024, twelve months to 2024-12-31. operating cash flow − capital expenditureOperating cash flow: $167.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-17, accession 0000816956-26-000009.Capital expenditure: $13.1m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-17, accession 0000816956-26-000009.Report this figure151Free cash flow, FY2025, twelve months to 2025-12-31. operating cash flow − capital expenditureOperating cash flow: $170.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-17, accession 0000816956-26-000009.Capital expenditure: $19.8m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-17, accession 0000816956-26-000009.Report this figure

Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.

Insider purchases and sales

All insider transactions

The last 20 open-market transactions reported on Form 4 (codes P and S). The reported price is the price per share the insider stated on the form: filing data, not a market price.

No open-market purchases or sales by insiders are in coverage from Nov 2024 to Oct 2026.

No open-market purchases or sales by insiders are in coverage for this company.

Funds that report holding it

All funds

From each manager's latest Form 13F, largest reported value first. Reported value is as filed at the quarter end: filing data, not a price. A put or call is an option position, not shares held.

Funds that report holding CONMED Corp
FundQuarter endedReported valueSharesPut or callChange on the quarter before
BlackRock, Inc.2026-06-30$157.8m4,820,739Reduced−4,434
EARNEST PARTNERS LLC2026-06-30$82.0m2,505,295Reduced−64,358
VANGUARD PORTFOLIO MANAGEMENT LLC2026-06-30$71.6m2,188,761Added+112,344
FULLER & THALER ASSET MANAGEMENT, INC.2026-06-30$51.7m1,579,917Reduced−61,849
STATE STREET CORP2026-06-30$46.4m1,417,468Added+33,450
VANGUARD CAPITAL MANAGEMENT LLC2026-06-30$44.4m1,355,728Reduced−28,314
BANK OF AMERICA CORP /DE/2026-06-30$43.9m1,341,409Reduced−61,211
DIMENSIONAL FUND ADVISORS LP2026-06-30$43.1m1,317,370Reduced−75,550
SEI INVESTMENTS CO2026-06-30$32.3m988,151Reduced−16,564
Invenomic Capital Management LP2026-06-30$27.6m842,162Reduced−92,439

Recent filings

All 1,640 filings

Reports and events: 10-K, 10-Q, 8-K, proxy statements and ownership schedules.

CONMED Corp, recent filings
FiledFormWhat it isAccession number
2026-07-2916:13 ET10-QQuarterly reportPeriod 2026-06-300000816956-26-000102
2026-07-2916:10 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000816956-26-000101
2026-06-1716:49 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0002077096-26-000203
2026-06-0407:30 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001174947-26-000639
2026-06-0108:31 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits0002077096-26-000190
2026-05-2008:30 ET8-K5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits0000816956-26-000057
2026-04-3009:52 ET10-QQuarterly reportPeriod 2026-03-310000816956-26-000053
2026-04-2916:18 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000816956-26-000051
2026-04-0708:23 ETDEF 14AProxy statementPeriod 2026-05-180000816956-26-000047
2026-03-1316:01 ET8-K5.02 Departure or appointment of officers or directors0001213900-26-027658

Latest annual report

Form 10-K for the fiscal year ended Dec 31, 2025Filed Feb 17, 2026. Its page lists the documents and the extracted sections, such as Business and Risk factors.

Forecast league

Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by [object Promise].Forecast this quarter

About the filer

CIK
816956
Tickers
CNMD
Exchange
NYSE
SIC code
3845 Electromedical & Electrotherapeutic Apparatus
Sector
Healthcare
Fiscal year ends
Dec 31
Incorporated in
DE
Filer category
Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:25 ET. Listed shows no prices and gives no investment advice.